There is no one size fits all with demonstrating economic value. Whether you need to develop a global approach or require economic support for local market access, we will diligently plan the model specification to fit your requirements, data availability, and disease area. We also have extensive experience in securely handling and analysing individual patient data (IPD) for direct incorporation into your model, working with our Statistics team as needed.
Costello Medical’s global presence and extensive experience in HTA, Literature Reviews, Market Access and RWE, means we have an intimate understanding of how your model fits within the wider strategic and industry context and what this means for the project approach. We take care to scope the disease area and policy context of each of our projects to provide strategic advice to clients and help them determine what is required to achieve their goals.
Our multidisciplinary approach combines a team of exceptional individuals with backgrounds in economics, mathematics and statistics, as well as science and clinical communication, allowing us to deliver insights relevant to clinical practice. Further, we are experienced in a range of expert elicitation exercises, including the use of our in-house Delphi app, to ensure the clinical robustness of all deliverables.
We believe that the key to persuading an audience to trust and understand your economic value is to be transparent and evidence-based both throughout model development and when disseminating the output of our work. We are experts in ensuring clear, accurate and compelling written and verbal communication of your model, including the provision of handover training and compliance support for field tools if needed. This is supported by our established track record for health economic-related publications.
20+
Countries
80+
Indications
25+
Clients
